Next Article in Journal
Vaccine Efficacy on the Novel Reassortant H9N2 Virus in Indonesia
Next Article in Special Issue
Genetic Co-Administration of Soluble PD-1 Ectodomains Modifies Immune Responses against Influenza A Virus Induced by DNA Vaccination
Previous Article in Journal
Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
Previous Article in Special Issue
A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults
 
 
Search for Articles:
Title / Keyword
Author / Affiliation
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 8
Issue 3
10.3390/vaccines8030448
vaccines-logo
Submit to this Journal Review for this Journal Edit a Special Issue
► Article Menu

Article Menu

share announcement question_answer thumb_up
...
textsms
...
Article

Immunogenicity and Protective Efficacy of Influenza A DNA Vaccines Encoding Artificial Antigens Based on Conservative Hemagglutinin Stem Region and M2 Protein in Mice

by
Sergei Bazhan
1,*,
Denis Antonets
1,
Ekaterina Starostina
2,
Tatyana Ilyicheva
3,
Olga Kaplina
2,
Vasiliy Marchenko
3,
Alexander Durymanov
3,
Svetlana Oreshkova
2 and
Larisa Karpenko
2
1
Theoretical Department, State Research Center of Virology and Biotechnology “Vector”, Koltsovo 630559, Novosibirsk Region, Russia
2
Bioengineering Department, State Research Center of Virology and Biotechnology “Vector”, Koltsovo 630559, Novosibirsk Region, Russia
3
Department of Zoonotic Infections and Influenza, State Research Center of Virology and Biotechnology “Vector”, Koltsovo 630559, Novosibirsk Region, Russia
*
Author to whom correspondence should be addressed.
Vaccines 2020, 8(3), 448; https://doi.org/10.3390/vaccines8030448
Received: 8 July 2020 / Revised: 4 August 2020 / Accepted: 6 August 2020 / Published: 9 August 2020
(This article belongs to the Special Issue Influenza Virus and Vaccine Development)
View Full-Text Download PDF
Browse Figures

Abstract

Background: Development of a universal vaccine capable to induce antibody responses against a broad range of influenza virus strains attracts growing attention. Hemagglutinin stem and the exposed fragment of influenza virus M2 protein are promising targets for induction of cross-protective humoral and cell-mediated response, since they contain conservative epitopes capable to induce antibodies and cytotoxic T lymphocytes (CTLs) to a wide range of influenza virus subtypes. Methods: In this study, we generated DNA vaccine constructs encoding artificial antigens AgH1, AgH3, and AgM2 designed on the basis of conservative hemagglutinin stem fragments of two influenza A virus subtypes, H1N1 and H3N2, and conservative M2 protein, and evaluate their immunogenicity and protective efficacy. To obtain DNA vaccine constructs, genes encoding the designed antigens were cloned into a pcDNA3.1 vector. Expression of the target genes in 293T cells transfected with DNA vaccine constructs has been confirmed by synthesis of specific mRNA. Results: Immunization of BALB/c mice with DNA vaccines encoding these antigens was shown to evoke humoral and T-cell immune responses as well as a moderated statistically significant cross-protective effect against two heterologous viruses A/California/4/2009 (H1N1pdm09) and A/Aichi/2/68 (H3N2). Conclusions: The results demonstrate a potential approach to creating a universal influenza vaccine based on artificial antigens. View Full-Text
Keywords: influenza virus; DNA-vaccine constructs; artificial polyepitope T-cell immunogens; hemagglutinin stem region; M2 protein; cross-protective influenza immunity influenza virus; DNA-vaccine constructs; artificial polyepitope T-cell immunogens; hemagglutinin stem region; M2 protein; cross-protective influenza immunity
►▼ Show Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
SciFeed

Share and Cite

MDPI and ACS Style

Bazhan, S.; Antonets, D.; Starostina, E.; Ilyicheva, T.; Kaplina, O.; Marchenko, V.; Durymanov, A.; Oreshkova, S.; Karpenko, L. Immunogenicity and Protective Efficacy of Influenza A DNA Vaccines Encoding Artificial Antigens Based on Conservative Hemagglutinin Stem Region and M2 Protein in Mice. Vaccines 2020, 8, 448. https://doi.org/10.3390/vaccines8030448

AMA Style

Bazhan S, Antonets D, Starostina E, Ilyicheva T, Kaplina O, Marchenko V, Durymanov A, Oreshkova S, Karpenko L. Immunogenicity and Protective Efficacy of Influenza A DNA Vaccines Encoding Artificial Antigens Based on Conservative Hemagglutinin Stem Region and M2 Protein in Mice. Vaccines. 2020; 8(3):448. https://doi.org/10.3390/vaccines8030448

Chicago/Turabian Style

Bazhan, Sergei, Denis Antonets, Ekaterina Starostina, Tatyana Ilyicheva, Olga Kaplina, Vasiliy Marchenko, Alexander Durymanov, Svetlana Oreshkova, and Larisa Karpenko. 2020. "Immunogenicity and Protective Efficacy of Influenza A DNA Vaccines Encoding Artificial Antigens Based on Conservative Hemagglutinin Stem Region and M2 Protein in Mice" Vaccines 8, no. 3: 448. https://doi.org/10.3390/vaccines8030448

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Map by Country/Region

1
Back to TopTop